Effectiveness of yearly, register based screening for chlamydia in the Netherlands: Controlled trial with randomised stepped wedge implementation

BMJ (Online)

Volumn 345, Issue 7869, 2012, Pages

  Van Den Broek, Ingrid V F ^a   Van Bergen, Jan E A M ^b,c   Brouwers, Elfi E H G ^d   Fennema, Johannes S A ^e   Götz, Hannelore M ^f   Hoebe, Christian J P A ^d   Koekenbier, Rik H ^e   Kretzschmar, Mirjam ^a,g   Over, Eelco A B ^a   Schmid, Boris V ^a   Pars, Lydia L ^c   Van Ravesteijn, Sander M ^f   Van Der Sande, Marianne A B ^a,g   De Wit, G Ardine ^a,g   Low, Nicola ^h   Op De Coul, Eline L M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^d South Limburg Public Health Service   (Netherlands)

^e MUNICIPAL HEALTH SERVICE   (Netherlands)

^f Public Health Service of the Rotterdam Region   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIA; CHLAMYDIASIS; CONTACT EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENERAL PRACTITIONER; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INTERNET; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PELVIC INFLAMMATORY DISEASE; POSTAL MAIL; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGISTER BASED SCREENING; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; SOCIAL STATUS; URINALYSIS; VAGINA SMEAR; CHLAMYDIA TRACHOMATIS; EARLY DIAGNOSIS; INCIDENCE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; TIME;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EARLY DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; NETHERLANDS; PREVALENCE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; TIME FACTORS; YOUNG ADULT;

EID: 84864870412     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e4316     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention. Sexually transmitted diseases guidelines, 2010. MMWR 2010;59:1-114.
2. Health Protection Agency. National chlamydia screening programme. Core requirements. 5th ed, update 2. Health Protection Agency, 2010.
3. Dutch Health Council. Screenen op Chlamydia. [Screening for Chlamydia.] Gezondheidsraad rapport. [Health Council Report.] Dutch Health Council, 2004.
4. UK National Screening Committee. UK screening portal. Programme appraisal criteria. 2011. www.screening.nhs.uk/cms.php?folder=2431.
5. National Chlamydia Screening Programme. The bigger picture. The national chlamydia screening programme 2008/09 annual report. 2011. www. chlamydiascreening.nhs.uk/ps/publications/reports.html.
6. Westr̈m L. Effect of pelvic inflammatory disease on fertility. Venereology 1995;8:219-22.
7. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6. (Pubitemid 26152715)
8. Østergaard L, Andersen B, Møller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000;31:951-7. (Pubitemid 32299353)
9. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010;340:c1642.
10. Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol 2009;38:435-48.
11. Low N. Screening programmes for chlamydial infection: when will we ever learn? BMJ 2007;334:725-8. (Pubitemid 46623736)
12. Low N, Cassell JA, Spencer B, Bender N, Martin Hilber A, van Bergen J, et al. Chlamydia control activities in Europe: cross-sectional survey. Eur J Public Health 2011: published online 29 April.
13. National Chlamydia Screening Programme. Chlamydia connects . The August 2011 eNewsletter from the NCSP. NCSP, 2011.
14. Woodhall SC, Mercer CH, Soldan K. Declining positivity among 15-24-year-olds screened for Chlamydia in England-a sign of falling prevalence or a symptom of changing uptake? Poster ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A113-4.
15. Batteiger BE, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010;201(Suppl 2):S178-89.
16. Mercer CH, Copas AJ, Sonnenberg P, Johnson AM, McManus S, Erens B, et al. Who has sex with whom? Characteristics of heterosexual partnerships reported in a national probability survey and implications for STI risk. Int J Epidemiol 2009;38:206-14.
17. Macleod J, Salisbury C, Low N, McCarthy A, Sterne JAC, Holloway A, et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 2005;330:940-2. (Pubitemid 40592313)
18. Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, et al, for the Chlamydia Screening Studies Project Group. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007;11:1-186.
19. Van Bergen J, Götz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ, et al. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 2005;81:17-23. (Pubitemid 40222861)
20. Van Bergen JE, Fennema JS, van den Broek IV, Brouwers EE, de Feijter EM, Hoebe CJ, et al. Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands. BMC Infect Dis 2010;10:293.
21. Van den Broek IV, Hoebe CJ, van Bergen JE, Brouwers EE, de Feijter EM, Fennema JS, et al. Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis. BMC Infect Dis 2010;10:89.
22. Op de Coul ELM, Götz HM, van Bergen JEAM, Fennema JSA, Hoebe CJPA, Koekenbier RH, et al. Who participates in the Dutch Chlamydia screening? A study on demographic and behavioural correlates of participation and positivity. Sex Transm Dis 2012;39:97-103.
23. Op de Coul ELM, Weenen TC, van der Sande MAB, van den Broek IVF. Process evaluation of the Chlamydia Screening Implementation in the Netherlands: phase 1. RIVM report 210261006. 2011. www.rivm.nl/bibliotheek/rapporten/210261006. html.
24. Dokkum NF, Koekenbier RH, van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, et al. Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based Chlamydia screening in the Netherlands. BMC Public Health 2012;12:176.
25. Greenland KE, Op de Coul EL, van Bergen JE, Brouwers EE, Fennema HJ, Götz HM, et al. Acceptability of the Internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse. Sex Transm Dis 2011;38:467-74.
26. Götz HM, van Bergen JE, Veldhuijzen IK, Broer J, Hoebe CJ, Steyerberg EW, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005;81:24-30. (Pubitemid 40222862)
27. Van den Broek IV, Brouwers EE, Go&dietz HM, van Bergen JE, Op de Coul EL, Fennema JS, et al. Systematic selection of screening participants by risk score in a chlamydia screening programme is feasible and effective. Sex Transm Infect 2012;88:205-11.
28. Bakker F, de Graaf H, de Haas S, Kedde H, Kruijer H, Wijsen C. Sexual health in the Netherlands. Rutgers Nisso Group Report, 2009.
29. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG, Donner A. Evaluation of health interventions at area and organisation level. BMJ 1999;319;376-9.
30. Riha J, Mercer CH, Soldan K, French CE, Macintosh M. Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data. Sex Transm Infect 2011;87:306-11.
31. Herrmann BF, Johansson AB, Mårdh PA. A retrospective study of efforts to diagnose infections by Chlamydia trachomatis in a Swedish county. Sex Transm Dis 1991;18:233-7.
32. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence in Chlamydia trachomatis infection associated with a selective screening program of family planning clinics in Wisconsin. Sex Transm Dis 1993;20:28-35. (Pubitemid 23082234)
33. Hillis SD, Nakashima A, Amsterdam L, Pfister J, Vaughn M, Addiss D, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect 1995;27:108-11.
34. Szczepura A, Price C, Gumber A. Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health 2008;8:346.
35. Gaydos CA, Dwyer K, Barnes M, Rizzo-Price PA, Wood BJ, Flemming T, et al. Internet-based screening for Chlamydia trachomatis to reach non-clinic populations with mailed self-administered vaginal swabs. Sex Transm Dis 2006;33:451-7. Erratum in: Sex Transm Dis 2007;34:625. (Pubitemid 43964756)
36. Gaydos CA, Barnes M, Aumakhan B, Quinn N, Agreda P, Whittle P, et al. Can e-technology through the Internet be used as a new tool to address the Chlamydia trachomatis epidemic by home sampling and vaginal swabs? Sex Transm Dis 2009;36:577-80.
37. Chai SJ, Aumakhan B, Barnes M, Jett-Goheen M, Quinn N, Agreda P, et al. Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sex Transm Dis 2010;37:756-63.
38. Low N, Egger M, Sterne JA, Harbord RM, Ibrahim F, Lindblom B, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect 2006;82:212-8. (Pubitemid 43901588)
39. Heijne JC, Tao G, Kent CK, Low N. Uptake of regular chlamydia testing by US women: a longitudinal study. Am J Prev Med 2010;39:243-50.
40. Van den Broek IVF, Götz HM, Brouwers EEHG, Fennema JSA, Hoebe CJPA, Koekenbier RH, et al. The contribution of a Chlamydia screening programme to testing and case-finding in addition to regular STI-care in three regions of The Netherlands. Poster ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A200-1.
41. Vriend HJ, Koedijk FDH, van den Broek IVF, van Veen MG, Op de Coul ELM, van Sighem AI, et al. Sexually transmitted infections, including HIV, in the Netherlands in 2010. RIVM report 210261009. 2011. www.rivm.nl/Thema-s/ Infectieziekten/Soa.
42. th IUSTI Europe Conference, September 2010, Tblisi, Georgia.
43. Op de Coul E, Götz H, van Bergen J, Brouwers E, Fennema H, Hoebe C, et al. Who participates in the Dutch chlamydia screening? A study on demographic and behavioural correlates of (repeated) participation and positivity. Poster ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A343.
44. Turner KM, Adams EJ, Lamontagne DS, Emmett L, Baster K, Edmunds WJ. Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect 2006;82:496-502. (Pubitemid 46025194)
45. Kretzschmar M, Turner KM, Barton PM, Edmunds WJ, Low N. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Sex Transm Infect 2009;85:359-66.
46. Schmid BV, van den Broek IVF, Op de Coul ELM, van Bergen JEAM, Fennema JSA, Götz HM, et al. Modelled impact of changing participation rates on effectiveness of population based Chlamydia screening. Oral presentation ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A45-6.
47. Schmid B, Over E, van den Broek I, Op de Coul E, van Bergen J, CSI Group, et al. Chlamydia screening implementation in the Netherlands is not cost-effective. Poster ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A344.
48. Götz HM, Op de Coul ELM, Brouwers EEHG, Fennema JSA, Hoebe CJPA, Koekenbier RH, et al. Reinfections, treatment and partner notification in a selective systematic internet based Chlamydia screening programme. Oral presentation ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A21-2.
49. Andersen B, Gundgaard J, Kretzschmar M, Olsen J, Welte R, Oster-Gaard L. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis infections. Sex Transm Dis 2006;33:407-15. (Pubitemid 43964749)
50. Anonymous. CMO's Expert advisory group on Chlamydia trachomatis. Department of Health, 1998.
51. Hocking JS, Temple-Smith M, Poznznski S, Guy R, Low N, Donovan B, et al ACCEPt Consortium. Australian chlamydia control effectiveness pilot: preliminary results from a trial of chlamydia testing in general practice. Poster ISSTDR Conference, 10-13 July 2011, Quebec, Canada. Sex Transm Infect 2011;87:A202.